Why the study?
Does MedPAR data identify a higher proportion of comorbidities compared to OASIS or home health care claims in Medicare beneficiaries with heart failure?
Does MedPAR data identify a higher proportion of comorbidities compared to OASIS or home health care claims in Medicare beneficiaries with heart failure?
MedPAR data identifies significantly more comorbidities than OASIS or home health claims, indicating it should be preferred for risk adjustment in home health care studies.
MedPAR data may identify more comorbidities in home health heart failure patients; leaves open optimal source for risk adjustment in observational studies.
We compare the proportion of patients presenting with comorbid conditions among fee-for-service Medicare beneficiaries with heart failure obtained by using (a) home health care claims data, (b) data from the Medicare Provider Analysis and Review (MedPAR), and (c) the Outcome and Assessment Information Set (OASIS), using a unique database developed by linking the records of Medicare administrative data and the OASIS. Data from the MedPAR yielded a higher proportion of patients with comorbid conditions compared to the OASIS or home health care claims data (77%, 51%, and 51%, respectively), leading us to conclude that non-home health care claims data must be used for risk adjustment in studies involving home health care patients.
No takes yet. Share an insight, caveat, or question.
Koroukian et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: